Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Rating of “Moderate Buy” by Brokerages

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned an average recommendation of “Moderate Buy” from the twenty-nine research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and twenty have assigned a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $509.0169.

ISRG has been the topic of a number of recent research reports. Raymond James Financial reissued an “outperform” rating and set a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Jefferies Financial Group reduced their target price on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. Evercore set a $430.00 price target on shares of Intuitive Surgical in a report on Monday, July 6th. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research note on Tuesday, June 2nd.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 6,634 shares of company stock worth $2,796,795. 0.60% of the stock is owned by insiders.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Newbridge Financial Services Group Inc. increased its stake in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares during the period. Main Street Group LTD acquired a new stake in Intuitive Surgical during the 1st quarter worth $30,000. Laurel Wealth Advisors LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth $31,000. Vermillion Wealth Management Inc. raised its position in shares of Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 25 shares during the last quarter. Finally, Turning Point Benefit Group Inc. lifted its stake in shares of Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $373.71 on Friday. The stock has a market cap of $132.02 billion, a P/E ratio of 42.81, a PEG ratio of 2.71 and a beta of 1.46. Intuitive Surgical has a one year low of $328.57 and a one year high of $603.88. The company has a fifty day moving average price of $393.78 and a 200 day moving average price of $446.25.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the business posted $1.81 EPS. As a group, equities research analysts anticipate that Intuitive Surgical will post 8.87 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.